Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD160 antibody (AA 27-136)

The Mouse Polyclonal anti-CD160 antibody has been validated for WB and ELISA. It is suitable to detect CD160 in samples from Human.
Catalog No. ABIN564827

Quick Overview for CD160 antibody (AA 27-136) (ABIN564827)

Target

See all CD160 Antibodies
CD160

Reactivity

  • 73
  • 19
  • 16
  • 1
Human

Host

  • 59
  • 19
  • 10
  • 1
  • 1
Mouse

Clonality

  • 60
  • 27
  • 2
Polyclonal

Conjugate

  • 45
  • 8
  • 6
  • 5
  • 4
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD160 antibody is un-conjugated

Application

  • 60
  • 40
  • 26
  • 15
  • 13
  • 13
  • 9
  • 5
  • 3
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA
  • Binding Specificity

    • 16
    • 9
    • 8
    • 5
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 27-136

    Purpose

    Mouse polyclonal antibody raised against a partial recombinant CD160.

    Sequence

    INITSSASQE GTRLNLICTV WHKKEEAEGF VVFLCKDRSG DCSPETSLKQ LRLKRDPGID GVGEISSQLM FTISQVTPLH SGTYQCCARS QKSGIRLQGH FFSILFTETG

    Cross-Reactivity

    Human

    Characteristics

    Antibody Reactive Against Recombinant Protein.

    Immunogen

    CD160 (AAH14465.1, 27 a.a. ~ 136 a.a) partial recombinant protein with GST tag.
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    50 % glycerol

    Handling Advice

    Aliquot to avoid repeated freezing and thawing.

    Storage

    -20 °C

    Storage Comment

    Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
  • Target

    CD160

    Alternative Name

    CD160

    Background

    Full Gene Name: CD160 Molecule
    Synonyms: BY55,FLJ46513,NK1,NK28

    Gene ID

    11126

    NCBI Accession

    NM_007053
You are here:
Chat with us!